Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Sana Biotechnology has closed its first round at more than $700m after investors including GV swung behind its vision to commercialise cell therapies.

The Lowe's-backed home finance provider increased its overall equity funding to more than $22m in a second series A tranche led by Omers Ventures.

Google's Gradient Ventures unit led a seed round for the online homeowners insurance platform late last year and has returned for its series A.

Sana Biotechnology has closed its first round with more than $700m after investors including GV swung behind its vision to commercialise cell therapies.

Ona Therapeutics is working on treatments for metastatic cancer and has collected series A funding from investors including Bpifrance.

Engrail Therapeutics has completed a series A round led by Nan Fung Life Sciences as it targets a validated mechanism-based approach to nervous system treatments.

Seed investor Toyota AI Ventures returned to help the intelligent forklift developer close a series A round led by Innovation Endeavors.

The capital markets data provider has completed a series A round led by Credit Suisse Asset Management’s Next Investors unit.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.